Oxford BioDynamics (LON:OBD) Share Price Passes Below 50-Day Moving Average – Time to Sell?

Oxford BioDynamics Plc (LON:OBD) shares passed below its 50-day moving average during trading on Wednesday . The stock has a 50-day moving average of GBX 0.27 and traded as low as GBX 0.25. Oxford BioDynamics shares last traded at GBX 0.25, with a volume of 2,200,347 shares.

Oxford BioDynamics Stock Performance

The company has a debt-to-equity ratio of 457.97, a quick ratio of 2.80 and a current ratio of 0.88. The stock has a market capitalization of £10.68 million, a P/E ratio of -0.31 and a beta of 0.42. The business has a 50-day moving average price of GBX 0.27 and a 200 day moving average price of GBX 0.34.

Oxford BioDynamics (LON:OBD) last released its earnings results on Wednesday, December 24th. The biotechnology company reported GBX (0.80) EPS for the quarter. Oxford BioDynamics had a negative return on equity of 316.67% and a negative net margin of 1,018.54%.

Oxford BioDynamics Company Profile

Oxford BioDynamics Plc is a global biotechnology company, advancing personalized healthcare by developing and commercializing precision medicine tests for life-changing diseases.

Its flagship product is EpiSwitch® CiRT (Checkpoint Inhibitor Response Test) for cancer, a predictive immune response profile for immuno-oncology (IO) checkpoint inhibitor treatments, launched in February 2022.

In March 2021, the Company launched its first commercial prognostic test, EpiSwitch® CST (Covid Severity Test) and the first commercially available microarray kit for high-resolution 3D genome profiling and biomarker discovery, EpiSwitch® Explorer Array Kit.